Review of generic drugs industry to go ahead, says trade commissionBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7293.1015/c (Published 28 April 2001) Cite this as: BMJ 2001;322:1015
- Scott Gottlieb
- New York
The US Federal Trade Commission is to conduct a wide ranging probe of whether the US drug industry conspires to keep lower cost generic drugs out of consumers' hands.
The move, announced in a statement issued by the commission, counters fears that the Bush administration, about to appoint a new head of the commission, might quash the investigation.
“We are preparing absolutely to go ahead with the study,” said commission spokesman Howard Shapiro, after it was reported that the Bush administration's Office of Management and Budget, headed by Mitch Daniels, a former executive of th/cdrug …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial